Lupin Pharmaceuticals recalls

Lupin Pharmaceuticals has 123 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 2 Sep 2026. 7 are still ongoing. 6 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls123since 2013
Last 12 months6reported
Class I54% of total
Ongoing7latest 2 Sep 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 5 4%Class II 78 63%Class III 40 33%

By year

Ongoing lupin pharmaceuticals recalls

7 active

All lupin pharmaceuticals recalls, newest first

123 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIClobetasol Propionate Cream USP, 05% tube recalledClobetasol PropionateLupin PharmaceuticalsOtherNationwide
DrugCLASS IIprednisoLONE Acetate Ophthalmic Suspension recalledPrednisolone AcetateLupin PharmaceuticalsSterilityNationwide
DrugCLASS IIGlucagon Emergency Kit for Low Blood Sugar, Glucagon recalledGlucagonLupin PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILiraglutide Injection, 18 mg/ (6 mg/mL) recalledLiraglutideLupin PharmaceuticalsParticulate MatterNationwide
DrugCLASS IISertraline Hydrochloride Tablets USP, 100 mg recalledSertraline HydrochlorideLupin PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IIGanirelix Acetate Injection, 250 mcg recalled by Lupin PharmaceuticalsGanirelix AcetateLupin PharmaceuticalsSterility4 states
DrugCLASS IIAmlodipine and Benazepril HCl Capsules USP 5 mg/10 mg recalledAmlodipine Besylate And Benazepril HydrochlorideLupin PharmaceuticalsOtherNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride Capsules USP 25 mg recalledClomipramine HydrochlorideLupin PharmaceuticalsPotency & AssayNationwide
DrugCLASS IILisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg recalledLisinopril And HydrochlorothiazideLupin PharmaceuticalsPackaging DefectsNationwide
DrugCLASS IIclomiPRAMINE hydrochloride Capsules USP, 25 mg recalledClomipramine HydrochlorideLupin PharmaceuticalsPotency & AssayNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.